Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Inventory: 2009-2025

Historic Inventory for Lifecore Biomedical (LFCR) over the last 17 years, with May 2025 value amounting to $32.3 million.

  • Lifecore Biomedical's Inventory fell 19.23% to $32.3 million in Q2 2025 from the same period last year, while for May 2025 it was $32.3 million, marking a year-over-year decrease of 19.23%. This contributed to the annual value of $32.3 million for FY2025, which is 19.23% down from last year.
  • Latest data reveals that Lifecore Biomedical reported Inventory of $32.3 million as of FY2025, which was down 19.23% from $40.0 million recorded in FY2024.
  • Lifecore Biomedical's Inventory's 5-year high stood at $40.8 million during FY2023, with a 5-year trough of $32.3 million in FY2025.
  • Its 3-year average for Inventory is $37.7 million, with a median of $40.0 million in 2024.
  • Its Inventory has fluctuated over the past 5 years, first slumped by 48.83% in 2021, then climbed by 13.45% in 2023.
  • Lifecore Biomedical's Inventory (Yearly) stood at $33.9 million in 2021, then grew by 6.10% to $36.0 million in 2022, then increased by 13.45% to $40.8 million in 2023, then decreased by 2.11% to $40.0 million in 2024, then dropped by 19.23% to $32.3 million in 2025.